TAKEDA 1 POINT Trademark

Trademark Overview

On Monday, January 30, 2017, a trademark application was filed for TAKEDA 1 POINT with the United States Patent and Trademark Office. The USPTO has given the TAKEDA 1 POINT trademark a serial number of 87318001. The federal status of this trademark filing is CANCELLED - SECTION 7 as of Wednesday, February 12, 2020. This trademark is owned by Takeda Pharmaceutical Company Limited. The TAKEDA 1 POINT trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Business administration of patient reimbursement program; business administration of medication reimbursement programs and services

Financial administration of patient reimbursement program; financial administration of medication reimbursement programs and services; providing insurance and insurance reimbursement information

Providing medical information to patients relating to the management of hematological malignancies, cancer, auto-immune and inflammatory diseases and disorders; providing information regarding medical services and therapeutic properties of pharmaceutical products to patients relating to the management of hematological malignancies, cancer auto-immune diseases and inflammatory diseases and disorders
takeda 1 point

General Information

Serial Number87318001
Word MarkTAKEDA 1 POINT
Filing DateMonday, January 30, 2017
Status711 - CANCELLED - SECTION 7
Status DateWednesday, February 12, 2020
Registration Number5885765
Registration DateTuesday, October 15, 2019
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 19, 2017

Trademark Statements

Indication of Colors claimedThe colors RED, GRAY and WHITE are claimed as a feature of the mark.
Description of MarkThe mark consists of the word "TAKEDA" in stylized red lettering on a white background appearing inside of two red intersecting curved lines, a gray vertical line in the middle of the mark, and the number "1" in white appearing in the overlapping center of one gray and one red triangle, which is partially obstructed by the letter "P" in the word "POINT" appearing to the right of the triangles in red stylized lettering.
Goods and ServicesBusiness administration of patient reimbursement program; business administration of medication reimbursement programs and services
Goods and ServicesFinancial administration of patient reimbursement program; financial administration of medication reimbursement programs and services; providing insurance and insurance reimbursement information
Goods and ServicesProviding medical information to patients relating to the management of hematological malignancies, cancer, auto-immune and inflammatory diseases and disorders; providing information regarding medical services and therapeutic properties of pharmaceutical products to patients relating to the management of hematological malignancies, cancer auto-immune diseases and inflammatory diseases and disorders
Pseudo MarkTAKEDA ONE POINT

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateWednesday, February 12, 2020
Primary Code035
First Use Anywhere DateMonday, August 27, 2018
First Use In Commerce DateMonday, August 27, 2018
International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateWednesday, February 12, 2020
Primary Code036
First Use Anywhere DateMonday, August 27, 2018
First Use In Commerce DateMonday, August 27, 2018
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateWednesday, February 12, 2020
Primary Code044
First Use Anywhere DateMonday, August 27, 2018
First Use In Commerce DateMonday, August 27, 2018

Trademark Owner History

Party NameTakeda Pharmaceutical Company Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressOsaka 540-8645
JP
Party NameTakeda Pharmaceutical Company Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOsaka 5408645
JP
Party NameTakeda Pharmaceutical Company Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka 540-8645
JP

Trademark Events

Event DateEvent Description
Wednesday, July 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 1, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, July 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 13, 2020NOTICE OF CANCELLATION SEC. 8 EMAILED
Wednesday, February 12, 2020CANCELLED SECTION 7-TOTAL
Wednesday, February 12, 2020NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED
Monday, January 6, 2020REQUEST FOR SECT 7 TOTAL SURRENDER FILED
Wednesday, February 5, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, January 6, 2020TEAS SECTION 7 SURRENDER RECEIVED
Tuesday, October 15, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, September 11, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 10, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, September 9, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 9, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 5, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 2, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 2, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 6, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 6, 2019NON-FINAL ACTION E-MAILED
Wednesday, March 6, 2019SU - NON-FINAL ACTION - WRITTEN
Wednesday, February 27, 2019STATEMENT OF USE PROCESSING COMPLETE
Friday, February 8, 2019USE AMENDMENT FILED
Wednesday, February 27, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 8, 2019TEAS STATEMENT OF USE RECEIVED
Saturday, August 11, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 9, 2018EXTENSION 1 GRANTED
Thursday, August 9, 2018EXTENSION 1 FILED
Thursday, August 9, 2018TEAS EXTENSION RECEIVED
Friday, June 22, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 13, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 19, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 19, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 29, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, November 11, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, November 11, 2017EXAMINER'S AMENDMENT ENTERED
Saturday, November 11, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, November 11, 2017EXAMINERS AMENDMENT E-MAILED
Saturday, November 11, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, November 9, 2017PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, November 9, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 16, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 16, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, October 15, 2017ASSIGNED TO LIE
Sunday, October 1, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, August 13, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, August 13, 2017LETTER OF SUSPENSION E-MAILED
Sunday, August 13, 2017SUSPENSION LETTER WRITTEN
Wednesday, July 19, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 19, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 19, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 19, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 11, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 17, 2017NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, February 17, 2017PRIORITY ACTION E-MAILED
Friday, February 17, 2017PRIORITY ACTION WRITTEN
Tuesday, February 14, 2017ASSIGNED TO EXAMINER
Friday, February 3, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, February 2, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 2, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

point takeda reimbursement administration information services diseases providing cancer hematological malignancies immune